SciELO - Scientific Electronic Library Online

 
vol.32 issue1Clinical implications of anti-HLA antibodies testing in kidney transplantationOff-target effects and adverse outcomes of fibroblast growth factor 23 in chronic kidney disease author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Portuguese Journal of Nephrology & Hypertension

Print version ISSN 0872-0169

Abstract

CORREIA, Sofia O; SANTOS, Sofia; MARTINS, La Salete  and  SANTOS, Josefina. Diagnosis of monoclonal gammopathy of renal significance. Port J Nephrol Hypert [online]. 2018, vol.32, n.1, pp.52-56. ISSN 0872-0169.

Monoclonal gammopathies are a heterogeneous group of disorders characterized by clonal proliferation of immunoglobulin produced by B-lymphocytes or plasma cell clone. The term monoclonal gammopathy of renal significance (MGRS) was introduced to distinguish monoclonal gammopathies that result in the development of kidney disease from those that are benign. Screening for monoclonal immunoglobulin and an appropriate hematologic workup are fundamental and sometimes a difficult challenge, with therapeutic and prognostic implications. Kidney biopsy is essential to determine the exact nature of the lesion and to evaluate the severity of renal disease. In this review we discuss the clinical and pathologic features of MGRS, highlighting the most diagnostic difficulties and current therapeutic options

Keywords : Monoclonal gammopathy of renal significance; M protein; renal pathology; treatment.

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License